3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Vomiting
6
Neoplasms
4
Nausea
3
Lymphoma
1
Leukemia
1
Breast Neoplasms
1
Interventions
pegylated granulocyte colony-stimulating factor
4
entecavir
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Brentuximab Vedotin
3
Aprepitant
3
Vinblastine
2
Prednisolone
2
Doxorubicin
2
Dexamethasone
2
rasburicase
1
prednylidene
1
plerixafor
1
peginterferon alfa-2b
1
pegfilgrastim
1
golimumab
1
fludarabine phosphate
1
fludarabine
1
fluarix
1
ferrous succinate
1
dexamethasone 21-phosphate
1
arexvy
1
abrysvo
1
Zidovudine
1
Water
1
Watchful Waiting
1
Vindesine
1
Vincristine
1
Valproic Acid
1
Urate Oxidase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoma
×
Palonosetron
×
Clear all
NCT00415103
2009-09-18
AMENO-2
PETHEMA Foundation
Phase 4
Completed
196 enrolled